MiniValuatorMiniValuator
    Valuator
  • Stock Valuations
  • AI AnalysisNew
  • Content
  • Pricing
MiniValuatorMiniValuator

A minimalist stock valuation tool. Born from our investing community.

Tools
DCF CalculatorPE CalculatorStock ComparisonsDCF ValuationsPE ValuationsPricing
Popular Stocks
AAPL Stock ValuationMSFT Stock ValuationGOOGL Stock ValuationAMZN Stock ValuationTSLA Stock ValuationView All
Learn
DCF MethodologyPE MethodologyGlossaryGuideBlog
Key Concepts
Intrinsic ValueFree Cash FlowWACCMargin of SafetyTerminal ValuePE Ratio
Community
About UsXiaohongshuNewsletter
Resources
AI Girl Generatorllms.txtllms-full.txt
Built for value investors
© 2024 MiniValuator, All rights reserved
Privacy PolicyTerms of Service
PE Valuations›Real Estate›VTR

Ventas, Inc. (VTR) Stock Valuation — PE Analysis

REIT - Healthcare Facilities · NYSE

Current Price

$87.37

Intrinsic Value

Use the calculator below to estimate

Calculate VTR Fair Value Using PE Ratio

Run a PE ratio stock valuation on Ventas, Inc. with auto-filled earnings data, adjustable target PE, and instant fair value estimate.

Open PE Calculator for VTR

Or try DCF Valuation for VTR →

Company Overview

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.

Financial Metrics — VTR PE Stock Valuation Data

Earnings Yield

0.63%

ROE (TTM)

2.1%

Based on trailing twelve-month data, VTR has earnings per share of N/A and trades at a PE ratio of N/A. These are key inputs for stock valuation using the PE ratio method.

Frequently Asked Questions

What is the PE ratio of VTR?

The trailing twelve-month PE ratio of VTR reflects how much investors pay per dollar of Ventas, Inc.'s earnings. This metric is most useful when compared to REIT - Healthcare Facilities peers and the company's own historical range.

Is VTR overvalued based on PE ratio?

Whether VTR is overvalued depends on comparing its PE ratio to REIT - Healthcare Facilities peers, historical averages, and growth expectations. A PE above the sector average may indicate overvaluation, but high-growth companies often command premium multiples. Consider pairing PE analysis with a DCF model for a more complete picture.

How do I value VTR stock using PE ratio?

To value Ventas, Inc. using PE: (1) Compare the current PE against the REIT - Healthcare Facilities median to assess relative pricing, (2) check the PEG ratio to adjust for growth expectations, (3) review the 5-year PE range to identify where the stock sits historically, and (4) estimate fair value by multiplying a target PE by forward EPS estimates. This relative approach complements DCF's absolute valuation.

What is the PEG ratio of VTR?

The PEG ratio divides the PE ratio by the expected earnings growth rate, providing a growth-adjusted valuation metric. A PEG below 1.0 may indicate undervaluation relative to growth, while above 2.0 may suggest overvaluation. PEG is most reliable for companies with stable, predictable earnings growth.

Should I use PE ratio or DCF for VTR stock valuation?

PE ratio gives a quick relative read — how VTR is priced versus REIT - Healthcare Facilities peers. DCF provides an absolute value based on projected free cash flows. For the most reliable valuation, use PE as a quick comparability screen and DCF for a deeper fundamental analysis. Each method has blind spots: PE ignores capital structure and cash flow quality, while DCF is sensitive to growth and discount rate assumptions.

Learn More

  • — AI-generated competitive moat and investment risk analysis
  • — Intrinsic value via Discounted Cash Flow analysis
  • — Step-by-step guide to PE ratio stock valuation
  • — Guide to discounted cash flow analysis
  • — Understanding the price-to-earnings ratio
  • — How to evaluate stock fair value

Related PE Valuations

VTR AI Moat & Risk Analysis →
See VTR DCF Valuation →
PE Methodology
DCF Methodology
PE Ratio
Intrinsic Value
AMTView PE
CCIView PE
SBACView PE
EQIXView PE
DLRView PE
IRMView PE
PLDView PE
STAGView PE